Oriola (CHIX:ORIOLH) Research & Development: €0 Mil (TTM As of Mar. 2026)


CHIX:ORIOLH Oriola Corp CHIX:ORIOLH
46 GF Score
Price €0.94
GF Value €1.00
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Oriola Research & Development?

Oriola CHIX:ORIOLH 46 Research & Development is €0 Mil as of Mar. 2026. GuruFocus rates CHIX:ORIOLH with a GF Score™ of 46/100 and a GF Value™ of €1.00 (Fairly Valued). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Oriola's Research & Development for the three months ended in Mar. 2026 was €0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €0 Mil.

Oriola  (CHIX:ORIOLh) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Oriola Research & Development Related Terms

Oriola Research & Development Historical Data

* Premium members only.

The historical data trend for Oriola's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oriola Research & Development Chart

Oriola Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Oriola Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
CHIX:ORIOLH
46GF Score
Oriola Corp CHIX:ORIOLH
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Oriola Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0 Mil mean?
Oriola (CHIX:ORIOLH) has a Research & Development of €0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Oriola and its competitors.
Is Oriola's Research & Development too high?
Oriola's current Research & Development is €0 Mil. Overall, Oriola has a GF Score™ of 46/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Oriola's Research & Development compare to competitors?
Oriola's Research & Development of €0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Oriola and its competitors. Oriola's current Research & Development is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oriola stock overvalued right now?
Based on GuruFocus' analysis, Oriola (CHIX:ORIOLH) is currently considered Fairly Valued. The stock's GF Value™ is €1.00, compared to a current price of €0.94 — trading 6.2% below its estimated fair value. The current Research & Development is €0 Mil. Oriola's overall GF Score™ is 46/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Oriola (CHIX:ORIOLH), the current Research & Development is €0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Oriola (CHIX:ORIOLH) Overvalued in 2026?

Based on GuruFocus' analysis, Oriola stock appears to be undervalued. The current stock price of €0.94 is trading 6.2% below its estimated GF Value™ of €1.00. GuruFocus considers Oriola to be Fairly Valued.

Key valuation signals for CHIX:ORIOLH:

  • Research & Development: €0 Mil
  • GF Value™: €1.00 vs. price of €0.94 (6.2% below fair value)
  • GF Score™: 46/100 with 5 warning signs

No single metric tells the full story. See the CHIX:ORIOLH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Oriola Business Description

Address Orionintie 5, P.O. Box 8, Espoo, FIN, FI-02200
Oriola Corp is a health and wellbeing company operating in Nordic countries. It offers services such as the distribution of pharmaceuticals and other health and well-being products, services, and dose dispensing. Oriola's operations are divided into two segments which include distribution and wholesale. Geographically, the company operates in Sweden, Finland and other countries generating majority revenue from the region of Sweden.
46GF Score

Get the complete analysis for CHIX:ORIOLH

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.94
Price
€1.00
GF Value